SHAREHOLDER ALERT: Weiss Law Investigates Imago BioSciences, Inc.
Provided By PR Newswire
Last update: Nov 21, 2022
NEW YORK, Nov. 21, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Imago BioSciences, Inc. ("Imago" or the "Company") (NASDAQ: IMGO), in connection with the tender offer for the Company by a subsidiary of Merck & Co., Inc. (NYSE: MRK). Under the tender offer terms, the Company's shareholders will receive $36.00 in cash for each share of Imago common stock owned. The transaction is valued at $1.35 billion.
Read more at prnewswire.com80.32
-1.03 (-1.27%)
Find more stocks in the Stock Screener
MRK Latest News and Analysis
2 days ago - ChartmillMERCK & CO. INC. (NYSE:MRK) - A Strong Value Pick in PharmaceuticalsMERCK & CO. INC. (NYSE:MRK) is a value stock with strong profitability, a healthy balance sheet, and an attractive dividend. Trading below industry valuations, it may appeal to long-term investors.
3 days ago - ChartmillTop S&P500 movers in Monday's pre-market sessionDiscover the top S&P500 movers in Monday's pre-market session and stay informed about market dynamics.
16 days ago - ChartmillMERCK & CO. INC. (NYSE:MRK) - A Reliable Dividend Stock with Strong FundamentalsMERCK & CO. (NYSE:MRK) offers a strong 4.2% dividend yield, consistent growth, and solid financial health, making it a top pick for dividend investors.
